Bioanalytical Method Validation: History, Process, and Regulatory Perspectives - Bioanalysis 2020

Patrick Faustino, CDER Office of Pharmaceutical Quality (OPQ), provides context for bioanalysis; explains the Bioanalytical Method Validation (BMV) guidance, history, process and procedures; and shares a foundational understanding of the importance of BMV.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2020 Playlist:    • 2020 CDER Small Business and Industry...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367